Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ATOS holding history

Atossa Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ATOS overviewAll 13F holders of ATOSFull Q2 2026 holdings

Shares (Q2 2026)
82,620
Value
$159.5K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of ATOS by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202682,620$159.5K<0.1%−9,414−10.2%ReducedHolders
Q1 202692,034$484.1K<0.1%+66,033+254.0%AddedConverted for a 1-for-15 splitHolders
Q4 2025390,008$230.1K<0.1%+129,286+49.6%AddedHolders
Q3 2025260,722$226.0K<0.1%−151,740−36.8%ReducedHolders
Q2 2025412,462$342.3K<0.1%−42,924−9.4%ReducedHolders
Q1 2025455,386$306.5K<0.1%−669,317−59.5%ReducedHolders
Q4 20241,124,703$1.06M<0.1%+1,053,910+1,488.7%AddedHolders
Q3 202470,793$107.6K<0.1%+29,342+70.8%AddedHolders
Q2 202441,451$49.3K<0.1%+41,028+9,699.3%AddedHolders
Q1 2024423$761<0.1%+393+1,310.0%AddedHolders
Q4 202330$26<0.1%−33,329−99.9%ReducedHolders
Q3 202333,359$24.6K<0.1%+33,359NewHolders
Q4 20220$00.0%−359−100.0%Sold outHolders
Q3 2022359$00.0%−5,434−93.8%ReducedHolders
Q2 20225,793$6.00K<0.1%−30,296−83.9%ReducedHolders
Q1 202236,089$45.0K<0.1%−36,732−50.4%ReducedHolders
Q4 202172,821$117.0K<0.1%+32,156+79.1%AddedHolders
Q3 202140,665$133.0K<0.1%+40,665NewHolders
Q2 20210$00.0%−26,170−100.0%Sold outHolders
Q1 202126,170$55.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.